|View printer-friendly version|
Histogenics Corporation to Participate in Upcoming Scientific and Investor Conferences
Cowen and Company Therapeutics Conference– New York, NY( October 5-6, 2015) Adam Gridley, Histogenics'CEO, will be participating in the event with investors and clinical experts, which will review key trends and developments in the most important therapeutic areas of the $500+ billion global drug market.
Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa– La Jolla, CA( October 7-9, 2015) Adam Gridley, Histogenics'CEO, will be presenting a corporate overview as part of the Meeting's Partnering Forumon Thursday, October 8, 2015, at 1:30 pm PDT. Co-hosted by the Alliance for Regenerative Medicine, the California Institute for Regenerative Medicine, and the Sanford Consortium for Regenerative Medicine, the 2015 Stem Cell Meeting on the Mesais a three-day conference featuring the program's two-day Partnering Forum, the Public Forumlecture, and a full-day scientific symposium.
BIO Investor Forum– San Francisco, CA( October 20-21, 2015) Adam Gridley, Histogenics'CEO, will be presenting a corporate overview on Tuesday, October 20, 2015. The BIO Investor Forumis an international biotech investor conference focused on early and established private companies as well as emerging public companies. The conference will explore trends and opportunities in life sciences, with a focus on venture-stage growth and emerging public companies as well as those poised to join the growth "watch list" in 2015.
Sofinnova Japan Biopharma Partnering Conference– Tokyo, Japan( October 27, 2015) Adam Gridley, Histogenics'CEO, will be presenting a corporate overview on Tuesday, October 27, 2015. The Sofinnova Japan Biopharma Partnering Conferencebrings together premier biotechnology companies from North Americaand Europewith influential Japanese licensing and business development executives.
The presentations that are webcast live may be accessed by visiting the Investor Relations section of
CONTACT: Investor Relations Tel: +1 (781) 547-7909 InvestorRelations@histogenics.com